Evelyn Partners Investment Management Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Evelyn Partners Investment Management Services's PFE Position: Q1 2026 in Review
Evelyn Partners Investment Management Services increased its Pfizer (PFE) stake by 13% in Q1 2026, buying an estimated $21.3K and bringing the position to 6,882 shares worth $193K. The position accounts for 0.02% of the portfolio, ranked #133.
Evelyn Partners Investment Management Services first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $447K in Q1 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Evelyn Partners Investment Management Services held 6,882 shares of Pfizer worth $193K as of Q1 2026.
- Evelyn Partners Investment Management Services bought 800 Pfizer shares in Q1 2026, an estimated $21.3K.
- Pfizer made up 0.02% of Evelyn Partners Investment Management Services's portfolio in Q1 2026, its #133 holding.
- Evelyn Partners Investment Management Services first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
- Evelyn Partners Investment Management Services's Pfizer position peaked at $447K in Q1 2025.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Evelyn Partners Investment Management Services's 13F filing for Q1 2026, filed 15 May 2026.